Oramed Pharmaceuticals
ORMP on XNAS, Oramed Pharmaceuticals Inc.
Measures activity, not value. Not investment advice.
Shares sold short (30 Oct 2026)
1.3M
-7.4% vs the report before
Short interest, % of shares outstanding
3.1%
43.5M shares outstanding (11 Nov 2026)
Days to cover
11.3
short interest / daily volume
Short sale volume share (20 Nov 2026)
36%
1-year median 43%
Sharp changes
23
short interest spike
FINRA short interest by settlement date (the 15th and the last business day of each month). FINRA publishes each report 7 business days after its settlement date. Dashed: 3-year median.
See the numbers
| 30 Oct 2026: 1.3M shares sold short, 11.3 days to cover |
| 15 Oct 2026: 1.5M shares sold short, 10.4 days to cover |
| 30 Sep 2026: 1.4M shares sold short, 7.3 days to cover |
| 15 Sep 2026: 1.3M shares sold short, 7.4 days to cover |
| 31 Aug 2026: 1.2M shares sold short, 4.3 days to cover |
| 14 Aug 2026: 1.0M shares sold short, 5.8 days to cover |
| 31 Jul 2026: 835K shares sold short, 5.7 days to cover |
| 15 Jul 2026: 765K shares sold short, 2.5 days to cover |
| 30 Jun 2026: 878K shares sold short, 1.2 days to cover |
| 15 Jun 2026: 570K shares sold short, 3.0 days to cover |
| 29 May 2026: 659K shares sold short, 3.1 days to cover |
| 15 May 2026: 635K shares sold short, 3.4 days to cover |
| 30 Apr 2026: 651K shares sold short, 4.5 days to cover |
| 15 Apr 2026: 577K shares sold short, 5.9 days to cover |
| 31 Mar 2026: 563K shares sold short, 5.5 days to cover |
| 13 Mar 2026: 542K shares sold short, 3.6 days to cover |
| 27 Feb 2026: 556K shares sold short, 3.6 days to cover |
| 13 Feb 2026: 540K shares sold short, 3.8 days to cover |
| 30 Jan 2026: 645K shares sold short, 2.6 days to cover |
| 15 Jan 2026: 409K shares sold short, 1.0 days to cover |
| 31 Dec 2025: 424K shares sold short, 3.4 days to cover |
| 15 Dec 2025: 315K shares sold short, 1.6 days to cover |
| 28 Nov 2025: 357K shares sold short, 1.0 days to cover |
| 14 Nov 2025: 245K shares sold short, 1.6 days to cover |
| 31 Oct 2025: 242K shares sold short, 2.1 days to cover |
| 15 Oct 2025: 209K shares sold short, 1.8 days to cover |
| 30 Sep 2025: 280K shares sold short, 2.3 days to cover |
| 15 Sep 2025: 224K shares sold short, 2.0 days to cover |
| 29 Aug 2025: 348K shares sold short, 4.2 days to cover |
| 15 Aug 2025: 364K shares sold short, 5.7 days to cover |
| 31 Jul 2025: 404K shares sold short, 5.2 days to cover |
| 15 Jul 2025: 404K shares sold short, 6.9 days to cover |
| 30 Jun 2025: 419K shares sold short, 5.8 days to cover |
| 13 Jun 2025: 475K shares sold short, 5.2 days to cover |
| 30 May 2025: 489K shares sold short, 5.8 days to cover |
| 15 May 2025: 591K shares sold short, 12.8 days to cover |
| 30 Apr 2025: 655K shares sold short, 13.7 days to cover |
| 15 Apr 2025: 709K shares sold short, 7.1 days to cover |
| 31 Mar 2025: 651K shares sold short, 14.9 days to cover |
| 14 Mar 2025: 665K shares sold short, 3.2 days to cover |
| 28 Feb 2025: 616K shares sold short, 3.1 days to cover |
| 14 Feb 2025: 576K shares sold short, 1.0 days to cover |
| 31 Jan 2025: 231K shares sold short, 1.9 days to cover |
| 15 Jan 2025: 248K shares sold short, 2.5 days to cover |
| 31 Dec 2024: 242K shares sold short, 1.2 days to cover |
| 13 Dec 2024: 291K shares sold short, 1.1 days to cover |
| 29 Nov 2024: 300K shares sold short, 2.4 days to cover |
| 15 Nov 2024: 314K shares sold short, 2.7 days to cover |
| 31 Oct 2024: 300K shares sold short, 4.5 days to cover |
| 15 Oct 2024: 298K shares sold short, 3.6 days to cover |
| 30 Sep 2024: 340K shares sold short, 3.9 days to cover |
| 13 Sep 2024: 354K shares sold short, 3.5 days to cover |
| 30 Aug 2024: 363K shares sold short, 3.0 days to cover |
| 15 Aug 2024: 237K shares sold short, 2.2 days to cover |
| 31 Jul 2024: 278K shares sold short, 3.5 days to cover |
| 15 Jul 2024: 335K shares sold short, 3.9 days to cover |
| 28 Jun 2024: 529K shares sold short, 2.0 days to cover |
| 14 Jun 2024: 468K shares sold short, 3.0 days to cover |
| 31 May 2024: 287K shares sold short, 2.6 days to cover |
| 15 May 2024: 305K shares sold short, 4.0 days to cover |
What the numbers say
- 1.3M shares sold short on 30 Oct 2026, 3.1% of shares outstanding, 11.3 days to cover; -7.4% on the report before (published by FINRA on 10 Nov 2026).
Every measure from this source
Short interest is a position, reported twice a month. Short sale volume is a different measure: the share of each day's trading on off-exchange venues that was a short sale. Market makers sell short routinely, so 40% to 50% is normal.
Sharp changes
23 in all loaded history, strongest first
Oramed Pharmaceuticals had 2.5M shares sold short in the 14 May 2021 report, 12× the same report last year.
Same report last year: 210K; its normal report is 257K.
See the evidence
- This period
- 2.5M (the 14 May 2021 report)
- Normal report (median of 24 earlier)
- 257K
- Typical spread (median absolute deviation)
- 73K
- How far from its usual level
- +20.8
- Same report last year
- 210K
- History used
- 1,232 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
Oramed Pharmaceuticals had 2.5M shares sold short in the 28 May 2021 report, 11× the same report last year.
Same report last year: 229K; its normal report is 268K.
See the evidence
- This period
- 2.5M (the 28 May 2021 report)
- Normal report (median of 24 earlier)
- 268K
- Typical spread (median absolute deviation)
- 93K
- How far from its usual level
- +16.1
- Same report last year
- 229K
- History used
- 1,246 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
Oramed Pharmaceuticals had 2.3M shares sold short in the 30 Apr 2021 report, 15× the same report last year.
Same report last year: 160K; its normal report is 245K.
See the evidence
- This period
- 2.3M (the 30 Apr 2021 report)
- Normal report (median of 24 earlier)
- 245K
- Typical spread (median absolute deviation)
- 60K
- How far from its usual level
- +23.5
- Same report last year
- 160K
- History used
- 1,218 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
Oramed Pharmaceuticals had 2.2M shares sold short in the 15 Apr 2021 report, 14× the same report last year.
Same report last year: 164K; its normal report is 231K.
See the evidence
- This period
- 2.2M (the 15 Apr 2021 report)
- Normal report (median of 24 earlier)
- 231K
- Typical spread (median absolute deviation)
- 51K
- How far from its usual level
- +26.3
- Same report last year
- 164K
- History used
- 1,203 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
Oramed Pharmaceuticals had 2.2M shares sold short in the 31 Mar 2021 report, 9.7× the same report last year.
Same report last year: 229K; its normal report is 229K.
See the evidence
- This period
- 2.2M (the 31 Mar 2021 report)
- Normal report (median of 24 earlier)
- 229K
- Typical spread (median absolute deviation)
- 43K
- How far from its usual level
- +31.4
- Same report last year
- 229K
- History used
- 1,188 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.
Oramed Pharmaceuticals had 1.8M shares sold short in the 12 Feb 2021 report, 3.3× the same report last year.
Same report last year: 550K; its normal report is 229K.
See the evidence
- This period
- 1.8M (the 12 Feb 2021 report)
- Normal report (median of 24 earlier)
- 229K
- Typical spread (median absolute deviation)
- 37K
- How far from its usual level
- +28.8
- Same report last year
- 550K
- History used
- 1,141 days
Fires when the period is at least 3.5 robust standard deviations above the company's own median, with 18+ earlier periods, 365+ days of history and a value of at least 500K.
Check it at the source: FINRA short interest data.